Advertisement

Pharmaceutisch Weekblad

, Volume 8, Issue 4, pp 223–228 | Cite as

Inclusion complexation of warfarin with cyclodextrins to improve some pharmaceutical characteristics

  • Shan-Yang Lin
  • Juei-Chyi Yang
Original Articles

Abstract

Inclusion complexation of warfarin and α- or β-cyclodextrins in water and in the solid phase were studied by a solubility method, a membrane permeation study, thin-layer chromatography, a dissolution study, IR spectroscopy and differential scanning calorimetry. The solubility of warfarin increased with the addition of cyclodextrins. The apparent stability constants of the α- and β-cyclodextrin complexes are 10.29M−1 and 148.88M−1 respectively. The greater the stability constant of the inclusion complex the lesser the permeability of warfarin. Solid complexes of warfarin and α- or β-cyclodextrins were obtained by freeze-drying. Clear differences in IR absorption spectra and DSC thermograms were observed between the inclusion complexes and physical mixtures. The dissolution rate of the freeze-dried warfarin-cyclodextrin complexes was increased about 1200-fold and 550-fold for α- and β-cyclodextrins, respectively. The dissolution rate of warfarin was significantly improved by complex formation.

Key words

Complexation Cyclodextrins Dissolution Permeability Solubility Warfarin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Szejtli J. Cyclodextrins and Their Inclusion Complexes. Budapest: Akademiai Kiado, 1982.Google Scholar
  2. 2.
    Saenger W. Cyclodextrin inclusion compounds in research and industry. Angew Chem Int Ed Engl 1980;19:344–62.CrossRefGoogle Scholar
  3. 3.
    Uekama K. Pharmaceutical applications of cyclodextrin complexation. Yakugaku Zasshi 1981;101:857–73.PubMedGoogle Scholar
  4. 4.
    Anonymous. Heparin and other anticoagulants. In: Reynolds EF, ed. Martindale The Extra Pharmacopoeia. 28th ed. London: The Pharmaceutical Press, 1982:762–82.Google Scholar
  5. 5.
    Sancilio LF, Taylor MA, Mathur PP, Crowe JP. Interaction between warfarin and nonsteroidal anti-inflammatory drug in rats. Life Sci 1985;36:1041–50.CrossRefPubMedGoogle Scholar
  6. 6.
    Ambre JJ, Fisher JJ. Effect of co-administration of aluminium and magnesium hydroxides on absorption of anticoagulants in man. Clin Pharmacol Ther 1973;14:231–7.PubMedGoogle Scholar
  7. 7.
    Akers MT, Lach JL, Fischer LJ. Bioavailability of dicumarol from different commercial tablets in dogs. J Pharm Sci 1973;62:1192–3.PubMedGoogle Scholar
  8. 8.
    Wagner JG, Welling PG, Lee KP, Walker JE.In vivo andin vitro availability of commercial warfarin tablets. J Pharm Sci 1971;60:666–77.PubMedGoogle Scholar
  9. 9.
    Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Inster 1965;4:117–212.Google Scholar
  10. 10.
    Lin SY. Determinations of inclusion complexation by partitioning method, conductometric titration and membrane permeation. Int J Pharm Tech Prod Manufac 1983;4:14–7.Google Scholar
  11. 11.
    Rosanske TW, Connors KA. Stoichiometric model of α-cyclodextrin complex formation. J Pharm Sci 1980;69:564–7.PubMedGoogle Scholar
  12. 12.
    Nakano M, Kuchiki A, Arita T. The effect of charges on permeabilities of drugs through collagen membranes. Chem Pharm Bull 1976;24:2345–9.PubMedGoogle Scholar
  13. 13.
    Otagiri M, Imai T, Matsuo N, Uekama K. Improvements to some pharmaceutical properties of flurbiprofen by β- and γ-cyclodextrin complexations. Acta Pharm Suec 1983;20:1–10.PubMedGoogle Scholar
  14. 14.
    Fujioka K, Kurosaki Y, Sato S, Noguchi T, Noguchi T, Yamahira Y. Pharmaceutical advantages of cyclodextrin complexes of bencyclane fumarate. Chem Pharm Bull 1983;31:2416–23.PubMedGoogle Scholar
  15. 15.
    Valente EJ, Lingafelter EC, Porter WR, Trager WF. Structure of warfarin in solution. J Med Chem 1977;20:1489–93.CrossRefPubMedGoogle Scholar
  16. 16.
    Stella VJ, Mooney KG, Pipkin JD. Dissolution and ionization of warfarin. J Pharm Sci 1984;73:946–8.PubMedGoogle Scholar
  17. 17.
    Uekama K, Fujinaga T, Hirayama F, Otagiri M, Yamasaki M. Inclusion complexations of steroid hormones with cyclodextrins in water and in solid phase. Int J Pharm 1982;10:1–15.CrossRefGoogle Scholar

Copyright information

© Bohn, Scheltema & Holkema 1986

Authors and Affiliations

  • Shan-Yang Lin
    • 1
  • Juei-Chyi Yang
    • 1
  1. 1.Biopharmaceutics Laboratory, Department of Medical Research Veterans General HospitalVACRSShih-Pai, TaipeiTaiwan, Republic of China

Personalised recommendations